(Q35809463)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

David Z Chang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Whitney Lomazow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

C Joy Somberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Rodica Stan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

207-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

Cancer antigens: immune recognition of self and altered self

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Strategies to overcome immune ignorance and tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Dendritic cells and immunotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Dendritic cell-based immunotherapy for the treatment of hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Route of immunization and the therapeutic impact of recombinant anticancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Heteroclitic immunization induces tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Prime-boost vaccines encoding an intracellular idiotype/GM-CSF fusion protein induce protective cell-mediated immunity in murine pre-B cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

DNA vaccination: transfection and activation of dendritic cells as key events for immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Tumor immunity and autoimmunity induced by immunization with homologous DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330410001701549

10.1080/10245330410001701549

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15204102%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference